BioLargo (NASDAQ:BLGO – Get Free Report) and FMC (NYSE:FMC – Get Free Report) are both construction companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, risk, dividends, valuation, earnings, analyst recommendations and profitability.
Valuation & Earnings
This table compares BioLargo and FMC”s top-line revenue, earnings per share (EPS) and valuation.
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
BioLargo | $12.23 million | 5.83 | -$3.50 million | ($0.03) | -8.00 |
FMC | $4.08 billion | 1.94 | $1.32 billion | $8.96 | 7.09 |
FMC has higher revenue and earnings than BioLargo. BioLargo is trading at a lower price-to-earnings ratio than FMC, indicating that it is currently the more affordable of the two stocks.
Analyst Ratings
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
BioLargo | 0 | 0 | 0 | 0 | N/A |
FMC | 1 | 10 | 5 | 1 | 2.35 |
FMC has a consensus target price of $68.63, suggesting a potential upside of 7.97%. Given FMC’s higher probable upside, analysts clearly believe FMC is more favorable than BioLargo.
Insider and Institutional Ownership
0.0% of BioLargo shares are owned by institutional investors. Comparatively, 91.9% of FMC shares are owned by institutional investors. 20.3% of BioLargo shares are owned by company insiders. Comparatively, 0.9% of FMC shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
Risk & Volatility
BioLargo has a beta of 0.2, suggesting that its stock price is 80% less volatile than the S&P 500. Comparatively, FMC has a beta of 0.85, suggesting that its stock price is 15% less volatile than the S&P 500.
Profitability
This table compares BioLargo and FMC’s net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
BioLargo | -16.53% | -58.35% | -32.12% |
FMC | 33.97% | 7.52% | 2.67% |
Summary
FMC beats BioLargo on 12 of the 14 factors compared between the two stocks.
About BioLargo
BioLargo, Inc. invents, develops, and commercializes various platform technologies. Its technologies solve challenging environmental problems comprising per – and polyfluoroalkyl substances (PFAS) water contamination, advanced water and wastewater treatment, industrial odor and volatile organic compounds control, air quality control, infection control, and myriad environmental remediation. The company provides full-service environmental engineering services. BioLargo, Inc. was incorporated in 1991 and is based in Westminster, California.
About FMC
FMC Corporation, an agricultural sciences company, provides crop protection, plant health, and professional pest and turf management products. It develops, markets, and sells crop protection chemicals that includes insecticides, herbicides, and fungicides; and biologicals, crop nutrition, and seed treatment products, which are used in agriculture to enhance crop yield and quality by controlling a range of insects, weeds, and diseases, as well as in non-agricultural markets for pest control. The company markets its products through its own sales organization and through alliance partners, independent distributors, and sales representatives. It operates in North America, Latin America, Europe, the Middle East, Africa, and Asia. The company was founded in 1883 and is headquartered in Philadelphia, Pennsylvania.
Receive News & Ratings for BioLargo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioLargo and related companies with MarketBeat.com's FREE daily email newsletter.